Porphyromonas gingivalis GroEL induces osteoclastogenesis of periodontal ligament cells and enhances alveolar bone resorption in rats

PLoS One. 2014 Jul 24;9(7):e102450. doi: 10.1371/journal.pone.0102450. eCollection 2014.

Abstract

Porphyromonas gingivalis is a major periodontal pathogen that contains a variety of virulence factors. The antibody titer to P. gingivalis GroEL, a homologue of HSP60, is significantly higher in periodontitis patients than in healthy control subjects, suggesting that P. gingivalis GroEL is a potential stimulator of periodontal disease. However, the specific role of GroEL in periodontal disease remains unclear. Here, we investigated the effect of P. gingivalis GroEL on human periodontal ligament (PDL) cells in vitro, as well as its effect on alveolar bone resorption in rats in vivo. First, we found that stimulation of PDL cells with recombinant GroEL increased the secretion of the bone resorption-associated cytokines interleukin (IL)-6 and IL-8, potentially via NF-κB activation. Furthermore, GroEL could effectively stimulate PDL cell migration, possibly through activation of integrin α1 and α2 mRNA expression as well as cytoskeletal reorganization. Additionally, GroEL may be involved in osteoclastogenesis via receptor activator of nuclear factor κ-B ligand (RANKL) activation and alkaline phosphatase (ALP) mRNA inhibition in PDL cells. Finally, we inoculated GroEL into rat gingiva, and the results of microcomputed tomography (micro-CT) and histomorphometric assays indicated that the administration of GroEL significantly increased inflammation and bone loss. In conclusion, P. gingivalis GroEL may act as a potent virulence factor, contributing to osteoclastogenesis of PDL cells and resulting in periodontal disease with alveolar bone resorption.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alveolar Bone Loss / genetics
  • Alveolar Bone Loss / metabolism
  • Alveolar Bone Loss / microbiology*
  • Alveolar Bone Loss / pathology
  • Animals
  • Bacterial Proteins / genetics*
  • Bacterial Proteins / metabolism
  • Bacterial Proteins / pharmacology
  • Chaperonin 60 / genetics*
  • Chaperonin 60 / metabolism
  • Chaperonin 60 / pharmacology
  • Gene Expression Regulation
  • Host-Pathogen Interactions
  • Humans
  • Integrin alpha1 / genetics
  • Integrin alpha1 / metabolism
  • Integrin alpha2 / genetics
  • Integrin alpha2 / metabolism
  • Interleukin-6 / biosynthesis
  • Interleukin-6 / metabolism
  • Interleukin-8 / biosynthesis
  • Interleukin-8 / metabolism
  • Male
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Osteoclasts / drug effects
  • Osteoclasts / metabolism
  • Osteoclasts / pathology*
  • Periodontal Ligament / microbiology*
  • Periodontal Ligament / pathology
  • Periodontitis / genetics
  • Periodontitis / metabolism
  • Periodontitis / microbiology*
  • Periodontitis / pathology
  • Porphyromonas gingivalis / genetics
  • Porphyromonas gingivalis / metabolism
  • Porphyromonas gingivalis / pathogenicity
  • RANK Ligand / genetics
  • RANK Ligand / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology

Substances

  • Bacterial Proteins
  • Chaperonin 60
  • IL6 protein, human
  • Integrin alpha1
  • Integrin alpha2
  • Interleukin-6
  • Interleukin-8
  • NF-kappa B
  • RANK Ligand
  • Recombinant Proteins
  • TNFSF11 protein, human

Grants and funding

This work was supported by National Science Council (NSC 101-2314 B-038-041-MY3), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.